Reconciling different infectivity estimates for HIV-1

被引:8
|
作者
Rapatski, Brandy L. [1 ]
Suppe, Frederick
Yorke, James A.
机构
[1] Stockton State Coll, NAMS, Pomona, NJ 08240 USA
[2] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA
[3] Univ Maryland, Dept Math, College Pk, MD 20742 USA
[4] Univ Maryland, Dept Phys, College Pk, MD 20742 USA
关键词
effective contact rate; HIV; infectiousness; mathematic model; transmission dynamics;
D O I
10.1097/01.qai.0000243095.19405.5c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In our article, "HIV-1 Epidemics Driven by Late Stage Disease," we conclude that the probability of transmission of HIV through promiscuous or casual sexual contacts is significantly higher in the third or symptomatic stage of the disease. Our results differ greatly from those of the current literature. The primary stage or first stage has been reported to be the most infectious based on an article by Jacquez et al. More recently, the Wawer et al study of monogamous heterosexual couples in Rakai, Uganda found that the transmission of HIV was most likely to occur in the first 5 months after infection. We describe how the findings of the Wawer et al study might be compatible with our results. We also respond to a response by Koopman and Simon, who seem to criticize their own paper severely and choose not to defend it against our remarks.
引用
收藏
页码:253 / 256
页数:4
相关论文
共 50 条
  • [21] Understanding the nature of the Nef requirement for HIV-1 infectivity
    Annachiara Rosa
    Massimo Pizzato
    Retrovirology, 10
  • [22] MECHANISMS OF INFECTIVITY AND REPLICATION OF HIV-1 AND IMPLICATIONS FOR THERAPY
    TERWILLIGER, EF
    SODROSKI, JG
    HASELTINE, WA
    ANNALS OF EMERGENCY MEDICINE, 1990, 19 (03) : 233 - 241
  • [23] Effect of protease inhibitors on HIV-1 maturation and infectivity
    Jardine, DK
    Tyssen, DP
    Birch, CJ
    ANTIVIRAL RESEARCH, 2000, 45 (01) : 59 - 68
  • [24] Rational engineering of a miniprotein inhibitor HIV-1 infectivity
    Vita, C
    Drakopoulou, E
    Vizzavona, J
    Rochette, S
    Martin, L
    Ménez, A
    Roumestand, C
    Yang, YS
    Ylisastigui, L
    Benjouad, A
    Gluckman, JC
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 516 - 518
  • [25] ATTENUATION OF HIV-1 INFECTIVITY BY AN INHIBITOR OF OLIGOSACCHARIDE PROCESSING
    DEDERA, D
    VANDERHEYDEN, N
    RATNER, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (06) : 785 - 794
  • [26] MECHANISM OF ENHANCEMENT OF VIRAL INFECTIVITY OF HIV-1 NEF
    GUATELLI, J
    CHOWERS, M
    PANDORI, M
    SPINA, C
    RICHMAN, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 190 - 190
  • [27] Early cytoplasmic uncoating is associated with infectivity of HIV-1
    Mamede, Joao I.
    Cianci, Gianguido C.
    Anderson, Meegan R.
    Hope, Thomas J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (34) : E7169 - E7178
  • [28] Understanding the nature of the Nef requirement for HIV-1 infectivity
    Rosa, Annachiara
    Pizzato, Massimo
    RETROVIROLOGY, 2013, 10 : S29 - S29
  • [29] BST-2 Diminishes HIV-1 Infectivity
    Zhang, Jianyong
    Liang, Chen
    JOURNAL OF VIROLOGY, 2010, 84 (23) : 12336 - 12343
  • [30] Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro
    McPhee, F
    Caldera, PS
    Bemis, GW
    McDonagh, AF
    Kuntz, ID
    Craik, CS
    BIOCHEMICAL JOURNAL, 1996, 320 : 681 - 686